Novo Nordisk A/S News Headlines

NVO 
$46.05
*  
0.36
0.78%
Get NVO Alerts
*Delayed - data as of Jul. 31, 2014  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Earnings and Sales Rise at Novo Nordisk - Analyst Blog
5/2/2013 8:52:43 AM - Zacks.com

Novo Nordisk and EMIS Modify Deal - Analyst Blog
5/1/2013 4:47:07 PM - Zacks.com

Positive Data on Lilly Diabetes Candidate - Analyst Blog
4/18/2013 3:17:53 PM - Zacks.com

Clean Superiority Sweep For Dulaglutide Could Reshape Diabetes Market
4/17/2013 4:24:00 PM - Seeking Alpha

The Seeking Alpha Experiment: Portfolio Introduction And 2013 Quarter 1 Review
4/12/2013 8:31:00 PM - Seeking Alpha

Top Notch Long-Term Dividend Growers
4/9/2013 3:59:00 PM - Seeking Alpha

Prolor Biotech: Unlimited Upside?
4/9/2013 8:36:00 AM - Seeking Alpha

Pipeline Progresses at Shire - Analyst Blog
4/5/2013 5:10:47 PM - Zacks.com

Glaxo Eyes Benlysta Label Expansion - Analyst Blog
4/5/2013 3:09:05 PM - Zacks.com

AstraZeneca Takes Over AlphaCore - Analyst Blog
4/4/2013 5:09:40 PM - Zacks.com

Conditional EU Approval for Pfizer's Bosulif - Analyst Blog
4/4/2013 3:08:00 PM - Zacks.com

Court Rules Against AstraZeneca - Analyst Blog
4/3/2013 5:22:08 PM - Zacks.com

A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
4/3/2013 10:04:00 AM - Seeking Alpha

Setback for Novartis in India - Analyst Blog
4/2/2013 6:19:11 PM - Zacks.com

Glaxo's Influenza Vaccine Gets CRL - Analyst Blog
4/1/2013 6:50:01 PM - Zacks.com

Pfizer's Xeljanz Approved in Japan - Analyst Blog
4/1/2013 6:19:01 PM - Zacks.com

Lilly Progresses with Empagliflozin - Analyst Blog
4/1/2013 6:07:01 PM - Zacks.com

Sanofi Invests in Emerging Markets - Analyst Blog
4/1/2013 5:10:27 PM - Zacks.com

Novo Nordisk: Buy This 10 Year 27.47% CAGR Stock After Its Recent 16.94% Pullback
4/1/2013 9:12:00 AM - Seeking Alpha

Sanofi/Transgene Inks Immunotherapy Deal - Analyst Blog
3/28/2013 6:30:43 PM - Zacks.com

FDA Approves Novartis' TOBI Podhaler - Analyst Blog
3/28/2013 5:26:42 PM - Zacks.com

AstraZeneca Discusses Strategy - Analyst Blog
3/28/2013 5:26:18 PM - Zacks.com

Bristol-Myers Reaches 52-Week High - Analyst Blog
3/28/2013 10:29:19 AM - Zacks.com

How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
3/28/2013 5:43:00 AM - Seeking Alpha

Sanofi Reports Lemtrada Data - Analyst Blog
3/27/2013 4:25:06 PM - Zacks.com